<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04868747</url>
  </required_header>
  <id_info>
    <org_study_id>NET-lidocaine-stomach cancer</org_study_id>
    <nct_id>NCT04868747</nct_id>
  </id_info>
  <brief_title>The Effect of Perioperative Lidocaine Infusion on Neutrophil Extracellular Trapping</brief_title>
  <official_title>The Effect of Perioperative Lidocaine Intravenous Infusion on Neutrophil Extracellular Trapping After Surgery for Stomach Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Catholic University of Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Catholic University of Korea</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the effect of perioperative lidocaine infusion on the neutrophil extracellular&#xD;
      trapping after minimally invasive surgery for stomach cancer&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate the effect of perioperative lidocaine infusion on the neutrophil extracellular&#xD;
      trapping, especially citrullinated histone3, neutrophil elastase, myeloperoxidase&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 5, 2021</start_date>
  <completion_date type="Anticipated">December 2027</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum concentration of NET(neutrophil extracellular trapping)-related biomarker</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>NET-related biomarker (citrullinated histone3, neutrophil elastase, myeloperoxidase)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>quality of recovery</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>The quality of recovery is assessed using questionnaire. This questionnaire includes 15 items. The score range is from 0 to 150. The higher score means the better quality of recovery after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>The postoperative pain is assessed using numeric rating scale (NRS; 0=no pain, 10=the maximal pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>survival of patients</measure>
    <time_frame>5 years</time_frame>
    <description>The survival of patients is assessed using electronic medical record.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The study group receives the intravenous 1% lidocaine 1.5 mg/kg bolus followed by 1.5 mg/kg/h during surgery and 1.0 mg/kg/h until 24 hours after surgery (Max.&lt;120 mg/h).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The control group receives intravenous normal saline 0.15 ml/kg bolus followed by 0.15 ml/kg/h during surgery and 0.1 mg/kg/h until 24 hours after surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>The participants receive perioperative lidocaine infusion with general anesthesia for gastrectomy.</description>
    <arm_group_label>study group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>The participants receive perioperative normal slaine infusion with general anesthesia for gastrectomy.</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diagnosis of stomach cancer&#xD;
&#xD;
          -  ASA class I-III&#xD;
&#xD;
          -  no metastatic disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  hepatic, renal disease&#xD;
&#xD;
          -  chronic inflammatory disease, eg. rheumatoid arthritis&#xD;
&#xD;
          -  steroid or anti-inflammatory drug medication&#xD;
&#xD;
          -  allergies to study drugs&#xD;
&#xD;
          -  neuropsychiatric disease&#xD;
&#xD;
          -  refusal of participation&#xD;
&#xD;
          -  breast feeding or pregnancy&#xD;
&#xD;
          -  weight &lt; 40 kg&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Young Eun Moon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul St. Mary's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Young Eun Moon, MD</last_name>
    <phone>822-2258-6163</phone>
    <email>0910momo@naver.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul St.Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Seocho-gu</state>
        <zip>07651</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <last_name>Young Eun Moon, MD</last_name>
      <phone>822-2258-6163</phone>
      <email>0910momo@naver.com</email>
    </contact>
    <contact_backup>
      <last_name>Nuri Lee, MD</last_name>
      <phone>822-2258-6162</phone>
      <email>snhkry55@naver.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 26, 2021</study_first_submitted>
  <study_first_submitted_qc>April 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2021</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Catholic University of Korea</investigator_affiliation>
    <investigator_full_name>Young Eun Moon</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

